Julie Jordan - Jan 16, 2024 Form 4 Insider Report for Neurogene Inc. (NGNE)

Role
Chief Medical Officer
Signature
/s/ Christine Mikail, as attorney-in-fact for Julie Jordan
Stock symbol
NGNE
Transactions as of
Jan 16, 2024
Transactions value $
$0
Form type
4
Date filed
1/18/2024, 06:48 PM
Previous filing
Aug 7, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NGNE Stock Option (Right to Buy) Award $0 +75K $0.00 75K Jan 16, 2024 Common Stock 75K $32.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents the right to purchase 75,000 shares of common stock of the Issuer, of which 25% vests on the first anniversary of the grant date and the remainder vests in equal monthly installments through January 16, 2028, subject to the reporting person's continued service to the Issuer through each applicable vesting date.